Published in Circulation on December 26, 2006
Structural basis of filamin A functions. J Cell Biol (2007) 2.60
The filamins: organizers of cell structure and function. Cell Adh Migr (2011) 2.50
Structure of three tandem filamin domains reveals auto-inhibition of ligand binding. EMBO J (2007) 1.85
Heart valve structure and function in development and disease. Annu Rev Physiol (2011) 1.80
Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol (2011) 1.73
Familial clustering of mitral valve prolapse in the community. Circulation (2014) 1.68
Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev (2012) 1.61
A novel interaction between FlnA and Syk regulates platelet ITAM-mediated receptor signaling and function. J Exp Med (2010) 1.45
Molecular basis of filamin A-FilGAP interaction and its impairment in congenital disorders associated with filamin A mutations. PLoS One (2009) 1.33
Allelic diversity in human developmental neurogenetics: insights into biology and disease. Neuron (2010) 1.17
Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. Eur J Hum Genet (2012) 1.14
Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell Tissue Res (2011) 1.10
Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene. Am J Hum Genet (2010) 1.04
RefilinB (FAM101B) targets filamin A to organize perinuclear actin networks and regulates nuclear shape. Proc Natl Acad Sci U S A (2011) 1.03
Mild expression of mitral valve prolapse in the Framingham offspring: expanding the phenotypic spectrum. J Am Soc Echocardiogr (2013) 1.02
Epidemiology and pathophysiology of mitral valve prolapse: new insights into disease progression, genetics, and molecular basis. Circulation (2014) 1.00
Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. Dev Dyn (2010) 1.00
Phosphorylation facilitates the integrin binding of filamin under force. Biophys J (2009) 0.99
Atrioventricular valve development: new perspectives on an old theme. Differentiation (2012) 0.98
Exon skipping causes atypical phenotypes associated with a loss-of-function mutation in FLNA by restoring its protein function. Eur J Hum Genet (2015) 0.96
The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it. Endocr Relat Cancer (2013) 0.96
R-Ras interacts with filamin a to maintain endothelial barrier function. J Cell Physiol (2011) 0.96
Complex roles of filamin-A mediated cytoskeleton network in cancer progression. Cell Biosci (2013) 0.95
Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics (2011) 0.93
Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves. J Mol Cell Cardiol (2013) 0.92
Genetic association analyses highlight biological pathways underlying mitral valve prolapse. Nat Genet (2015) 0.91
Developmental basis for filamin-A-associated myxomatous mitral valve disease. Cardiovasc Res (2012) 0.90
The living aortic valve: From molecules to function. Glob Cardiol Sci Pract (2014) 0.89
Differences in Copy Number Variation between Discordant Monozygotic Twins as a Model for Exploring Chromosomal Mosaicism in Congenital Heart Defects. Mol Syndromol (2012) 0.88
Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells. Arterioscler Thromb Vasc Biol (2014) 0.88
Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J Biol Chem (2014) 0.88
Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform. Eur J Hum Genet (2014) 0.88
Combined cardiological and neurological abnormalities due to filamin A gene mutation. Clin Res Cardiol (2010) 0.86
Mitral valve disease-morphology and mechanisms. Nat Rev Cardiol (2015) 0.84
Periventricular Heterotopia: Shuttling of Proteins through Vesicles and Actin in Cortical Development and Disease. Scientifica (Cairo) (2012) 0.83
Basic mechanisms of mitral regurgitation. Can J Cardiol (2014) 0.83
The genetic basis of aortic aneurysm. Cold Spring Harb Perspect Med (2014) 0.82
Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation. Biochim Biophys Acta (2013) 0.82
Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients. J Cancer Res Clin Oncol (2014) 0.81
A novel structural unit in the N-terminal region of filamins. J Biol Chem (2014) 0.81
Translational research on the mitral valve: from developmental mechanisms to new therapies. J Cardiovasc Transl Res (2011) 0.80
The role of pygopus in the differentiation of intracardiac valves in Drosophila. Genesis (2013) 0.80
Documentation and localization of force-mediated filamin A domain perturbations in moving cells. Nat Commun (2014) 0.79
New biomarkers for primary mitral regurgitation. Clin Proteomics (2015) 0.79
Degenerating heart valves: fill them up with filamin? Circulation (2007) 0.78
Mitral valve prolapse: a deeper look. JACC Cardiovasc Imaging (2008) 0.78
Genetics of valvular heart disease. Curr Cardiol Rep (2014) 0.77
Targeted Mybpc3 Knock-Out Mice with Cardiac Hypertrophy Exhibit Structural Mitral Valve Abnormalities. J Cardiovasc Dev Dis (2015) 0.77
Grb7 and Filamin-a associate and are colocalized to cell membrane ruffles upon EGF stimulation. J Mol Recognit (2013) 0.76
Myxomatous leaflet biological aberrations and potential therapeutic targets. Ann Cardiothorac Surg (2015) 0.75
MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions. J Cardiovasc Dev Dis (2015) 0.75
Lung Transplantation for FLNA-Associated Progressive Lung Disease. J Pediatr (2017) 0.75
Smooth muscle filamin A is a major determinant of conduit artery structure and function at the adult stage. Pflugers Arch (2016) 0.75
Sudden cardiac arrest associated with early repolarization. N Engl J Med (2008) 8.26
Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nat Genet (2006) 6.15
Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature (2003) 5.94
Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation (2003) 5.85
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm (2009) 4.99
Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet (2003) 3.23
Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome. Nat Genet (2012) 2.80
Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol (2002) 2.58
Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest (2008) 2.54
Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations. Am J Hum Genet (2005) 2.40
Identification of a strong genetic background for progressive cardiac conduction defect by epidemiological approach. Heart (2012) 2.39
Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation (2007) 2.38
Clinical aspects and prognosis of Brugada syndrome in children. Circulation (2007) 2.29
Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. J Am Coll Cardiol (2009) 2.21
Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel. J Cardiovasc Electrophysiol (2009) 2.20
Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation. Europace (2013) 2.14
De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet (2011) 2.09
A mechanism for gene-environment interaction in the etiology of congenital scoliosis. Cell (2012) 2.08
Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am J Hum Genet (2004) 2.04
Unknown complication of arterial switch operation: resistant hypertension induced by a strong aortic arch angulation. Circulation (2013) 2.02
Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome. Nat Genet (2005) 1.98
MOG1: a new susceptibility gene for Brugada syndrome. Circ Cardiovasc Genet (2011) 1.97
KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron. Nat Genet (2012) 1.93
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm (2009) 1.92
Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Hum Mutat (2010) 1.88
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet (2013) 1.86
Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. J Am Coll Cardiol (2011) 1.82
Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82
Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation (2005) 1.78
Exome sequencing identifies a DYNC1H1 mutation in a large pedigree with dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet (2011) 1.77
Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci U S A (2008) 1.72
RAD21 mutations cause a human cohesinopathy. Am J Hum Genet (2012) 1.72
Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human. Hum Mol Genet (2012) 1.64
SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet (2009) 1.64
Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol (2006) 1.63
Are women with severely symptomatic brugada syndrome different from men? J Cardiovasc Electrophysiol (2008) 1.62
Right ventricular systolic function in organic mitral regurgitation: impact of biventricular impairment. Circulation (2013) 1.58
Temporal arteritis associated with systemic necrotizing vasculitis. J Rheumatol (2003) 1.57
Dysmorphology of Barth syndrome. Clin Dysmorphol (2009) 1.56
Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies. Heart Rhythm (2008) 1.56
Scoping review on search queries and social media for disease surveillance: a chronology of innovation. J Med Internet Res (2013) 1.55
Mutations in the TGFβ binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. Am J Hum Genet (2011) 1.55
Atherosclerotic-like process in aortic stenosis: activation of the tissue factor-thrombin pathway and potential role through osteopontin alteration. Atherosclerosis (2010) 1.52
Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs. Nat Genet (2005) 1.51
Parental electrocardiographic screening identifies a high degree of inheritance for congenital and childhood nonimmune isolated atrioventricular block. Circulation (2012) 1.50
Identification of large families in early repolarization syndrome. J Am Coll Cardiol (2013) 1.50
The feasibility of MR-image guided prostate biopsy using piezoceramic motors inside or near to the magnet isocentre. Med Image Comput Comput Assist Interv (2006) 1.49
A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet (2011) 1.48
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges. Europace (2009) 1.47
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation (2006) 1.46
Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry. Eur J Echocardiogr (2010) 1.43
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace (2010) 1.40
Search for Rare Copy-Number Variants in Congenital Heart Defects Identifies Novel Candidate Genes and a Potential Role for FOXC1 in Patients With Coarctation of the Aorta. Circ Cardiovasc Genet (2015) 1.38
A mother and daughter with a novel phenotype of hand and foot abnormalities and severe pectus excavatum. Am J Med Genet A (2013) 1.38
Genomewide linkage searches for Mendelian disease loci can be efficiently conducted using high-density SNP genotyping arrays. Nucleic Acids Res (2004) 1.37
8p23.1 duplication syndrome; a novel genomic condition with unexpected complexity revealed by array CGH. Eur J Hum Genet (2007) 1.36
Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. J Am Coll Cardiol (2003) 1.34
Barth syndrome. Orphanet J Rare Dis (2013) 1.33
Refined genotype-phenotype correlations in cases of chromosome 6p deletion syndromes. Eur J Hum Genet (2004) 1.31
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29
Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol (2011) 1.29
Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model. PLoS One (2010) 1.26
Loss-of-function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance. Hum Mol Genet (2014) 1.25
Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial. Eur Heart J (2010) 1.23
Novel heterozygous OTX2 mutations and whole gene deletions in anophthalmia, microphthalmia and coloboma. Hum Mutat (2008) 1.21
How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet (2011) 1.20
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2. Circulation (2013) 1.20
Frontometaphyseal dysplasia: mutations in FLNA and phenotypic diversity. Am J Med Genet A (2006) 1.20
Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. J Cardiovasc Electrophysiol (2003) 1.20
Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development. Nat Genet (2013) 1.18